Skip to content
★ Sign in to follow
디오

디오 Stock: price and insider trades · South Korea

KR·Mcap ₩125.2BHealth Care

No insider purchase over the last 90 days. The latest, by 오윤석, was filed 18 May 2026.

디오: what insiders have been doing

Every trade that managers of 디오 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. In the past year (2 November 2025 to 2 November 2026), 3 filings came from 3 insiders.

No insider sold shares on the market over the period. Instead, the filings list 3 purchases, made by 3 insiders. No amount is published for 3 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 senior executive and 1 chief executive.

The last insider purchase was made public on 18 May 2026, 176 days ago.

Compared with its exchange (2,655 companies, median 7 filings), a count of 3 filings is below the norm. Over the whole record (from 2021), the tally stands at 9 purchases and 1 sale.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
24
Thresholds
n/a
Buy Volume
€9M
9 ops. · all time
Sell Volume
€3M
1 ops. · all time

Who traded when

BuySale
김종원1 buy
디오홀딩스1 buy
오윤석1 buy

Since the insiders bought

  • Filed 02 Apr 2026 · 222 days ago · €42k
    -40.3%
    Entry ₩16,370 · Close 30 Oct 2026 ₩9,780

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 17,114 of 26,911 companies
42.8
score / 100
Value
40
Quality
46
FCF yld10%
Earn yld-1.2%
EV/EBITDA27.7x
ROE12%
Gross mgn67%
Net mgn-0.8%
Debt/EBITDA11.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩9,780
Analyst consensus
3 analysts
·
₩16,000Target ₩19,000(+94%)₩25,000
Income statement
Revenue₩164.1B
Gross profit₩110.2B67% margin
EBITDA₩7B4% margin
Net income-₩1.4B12.7% margin
Valuation
PER (forward)4.8x
Beta0.59
Balance sheet & cash
Market cap₩125.2B
Total debt₩80.9B
Free Cash Flow₩11.6B
Debt / Equity45%
Profitability & ownership
ROE11.5%
ROA2.5%
% insiders37.0%
% institutions1.8%
Last declaration on 18 May 2026
Declarations25 total
  • Other
    Other(filed)
    0DART
  • ▲
    부사장Executives(filed)
    €13kest.0DART
    1,392 sharesShareKRXDART:20260518000254
    Canonical exit: 16 Aug 2026 (T+90)
  • ▲
    대표이사(사장)Executives(filed)
    €39kest.0DART
    4,378 sharesShareKRXDART:20260518000246
    Canonical exit: 16 Aug 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    €42kest.0DART
    4,542 sharesKRXDART:20260402000903
    Canonical exit: 23 Jun 2026 (T+90)
  • ▲
    대표이사(사장)Executives(filed)
    €50kest.0DART
    4,542 sharesShareKRXDART:20241029000132
    Canonical exit: 27 Jan 2025 (T+90)
  • ▲
    부사장Executives(filed)
    €22kest.0DART
    2,030 sharesShareKRXDART:20241029000166
    Canonical exit: 27 Jan 2025 (T+90)
  • ▲
    부사장Executives(filed)
    €15kest.0DART
    1,372 sharesShareKRXDART:20241029000135
    Canonical exit: 27 Jan 2025 (T+90)
  • ▲
    대표이사(사장)Executives
    0DART
    ShareKRXDART:20241029000137
    Canonical exit: 20 Jan 2025 (T+90)
  • ●
    Related company / holdingExecutives
    0DART
    0KRXDART:20240703000602
  • ●
    Related company / holdingExecutives
    0DART
    0KRXDART:20230824000364
  • ▼
    Related company / holdingExecutives(filed)
    €3.3Mest.0DART
    185,520 sharesKRXDART:20230302000405
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20221122000222
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20220920000225
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20220831000566
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20220830001277
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20220829000456
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20220701000505
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20220613000294
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20220609000579
  • ▲
    Related company / holdingExecutives(filed)
    €8.6Mest.0DART
    336,041 sharesKRXDART:20220321000569
    Canonical exit: 19 Jun 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    4,278,009 sharesKRXDART:20220318001033
    Canonical exit: 16 Jun 2022 (T+90)
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20210826000083
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20210813000208
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20210727000205
  • ●
    Related company / holdingExecutives(filed)
    0DART
    0KRXDART:20210723000401

25 of 25 declarations

About 디오

디오 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations